ADVANCE: STEM CELL FIGHTS MULTIPLE SCLEROSIS

ADVANCE: STEM CELL FIGHTS MULTIPLE SCLEROSIS
Stem cell and medicine

For more than two decades, stem cells have been sold in the media, cinema and television as a magical solution that opens the doors in medicine. However, those who enter more on the subject, do not take long to realize that their uses are, in a certain way, limited.

According to the International stem cell research society, there are still very few studies with favorable results where stem cells are used to meet diseases.

However, recent studies suggest that, precisely stem cells could mean an opportunity for those who suffer from multiple sclerosis.

HOW  DOES MULTIPLE SCLEROSIS WORK?

HOW  DOES MULTIPLE SCLEROSIS WORK?
Autoimmune cell

In countries such as Denmark, Sweden, Hungary and Cyprus, statistically known for being those with more volume of cases, 1 in 300 people suffer from multiple sclerosis. In many of these cases, this disease derives in disability or reduced mobility, due to its aggressive attack on the nervous system.

Due to a disorder in the behavior of autoimmune cells, the organism attacks the myelin that covers each neuron, affecting communication between the brain and the rest of systems, organs and other tissues that make up the human body.

 

A NEW STUDY DESIGNED G¡FOR ACUTE CASES

At the beginning of 2023, the American Academy of Neurology published through its magazine ‘Neurology’ an Italian study where the use of stem cells in patients with progressive secondary multiple sclerosis was studied.

These types of patients, like others affected by the disease, are characterized by outbreaks and remissions of aggressive symptoms video porno, deriving in medium or long -term disability.

The study consisted of the injection of blood cells of a healthy body in the patient’s body, as a measure to replace sick cells.

 

HOW DID THE STUDY BE CARRIED OUT?

To perform the experiment, a retrospective analysis of 79 cases of active progressive secondary sclerosis was carried out. Each received a stem cell transplant, and then compare the behavior of the disease with a database of 1975 patients with similar pictures, but treated with drugs.

The two groups were segmented by age, sex and degree of disability, and each patient was assigned a score from 0 to 10, according to the expanded scale of the state of disability. Subsequently, the progress of his illness was studied in a period of 10 years.

HOW DID THE STUDY BE CARRIED OUT?
(Pexel)

At the beginning of the study, the average punctuation of the patients was 6.5, in need of moving using orthopedic or cane apparatus. However, over time, considerable improvement was observed in indicators for patients undergoing stem cell treatment.

 

ANALYSIS OF RESULTS

When performing an analysis of the cases, it could be concluded that the use of stem cells began to progressively reduce the progress of the disease in patients, allowing them an extension in their quality of life. The measure was, in numerous cases, much more effective than the use of conventional multiple sclerosis.

Although long -cell treatment with stem cells for this disease has already been considered effective, until then it had only been tested with more premature states of it. However, the treatment was effective even in patients with more serious and advanced paintings.

Without a doubt, this represents a hope for patients who, for one reason, handle an acute picture of the disease.

 

Related Posts

 

WHAT DISEASES CAN BE TREATED WITH STEM CELLS?

WHAT DISEASES CAN BE TREATED WITH STEM CELLS?

Little by little, technology and scientific advances are breaking down the limitations of modern medicine. Today there are alternative treatments with high rates of effectiveness for diseases that were previously considered a death sentence.

We owe part of this significant advance to stem cells, the body’s raw material that gives life to other cells with specialized functions, such as heart, brain, bone, etc. That is, cells capable of replacing cells affected by a disease.

Although there are many chronic diseases and other conditions treated with stem cells, today we present 3 of them that stand out among the others for their significant advances in recent years xnxx.

what are stem cells?

Stem cells: What they are and what they do

DIABETES

DIABETES

Today, diabetes is no stranger to anyone. Whether you yourself or someone close to you suffers from it, surely you have been able to see its effects on your health: living with daily insulin injections and keeping a strict control to avoid permanent damage to the human body as much as possible.

Although the specific causes that cause its appearance are certainly not known, the possibility of using stem cells to destroy and replace the cells that cause type 1 diabetes is currently being studied.

At the moment, research continues at the level of clinical trials with species of devices to protect the immune system of patients. However, there are also other studies trying to prove using stem cells to promote the reproduction of healthy pancreatic cells in a natural way.

MYOCARDIAL INFARCTIONS

MYOCARDIAL INFARCTIONS

Many call him “The Silent Killer”. A fear with which one lives constantly, knowing how statistically possible its appearance is in any patient. Not surprisingly, at least 7 million heart attacks are recorded each year, in addition to being the leading cause of death in Europe.

As with diabetes, little is known specifically about heart attacks. The generation of new cardiomyocytes remains a mystery to medicine. However, the possibility of using stem cells to regenerate a heart affected by myocardial infarction is being studied.

However, at the moment, it remains somewhat tested on animals.

LEUKEMIA

LEUKEMIA

Not surprisingly, patients with advanced leukemia have been the first to experiment with stem cells. Especially, understanding that this disease is born from mutations in the systems linked to the creation of blood tissues.
One of the approaches that has received the most attention in the world of medicine is the one that seeks to use stem cells to create healthy autoimmune cells.

MULTIPLE SCLEROSIS

MULTIPLE SCLEROSIS

Perhaps this is, just after cancer in any of its forms, one of the cruelest and most common diseases at the same time. Multiple sclerosis is silent, painful and, at least for now, very difficult to stop.

For this reason, scientific researchers seek to use stem cells to intervene positively in the repair of myelin damage to cells.

Some approaches involve using chemotherapy to destroy the patient’s current immune system and then using stem cells to restore it. However, it is still an extremely high and risky bet.

On the other hand, the possibility of using stem cells to repair nerves affected by sclerosis is also being studied.
With the growing technological advances that continue to revolutionize the world of medicine, what other diseases do you think can be cured with stem cells?

 

 

Related Posts

More US patents on stem cells

6,238,429  Biologic cabling  
6,235,970  CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus  
6,235,969  Cloning pigs using donor nuclei from non-quiescent differentiated cells  
6,235,878  Fas ligand-like protein, its production and use  
6,235,708  Testis-specific cystatin-like protein cystatin T  
6,235,481  Polynucleotides encoding calpain 10  
6,231,893  Immunosuppressive and tumour-suppressive bone marrow factor  
6,228,639  Vectors and methods for the mutagenesis of mammalian genes  
6,228,591  Polycystic kidney disease PKD2 gene and uses thereof  
6,228,583  Assays for compounds which extend life span  
6,225,525  ATP-binding cassette transporter (ABC1) modified transgenic mice  
6,225,456  Ras suppressor SUR-5  
6,225,121  Eukaryotic transposable element  
6,225,101  Isolated Myt1 polypeptide  
6,225,085  LRSG protein and nucleic acid molecules and uses therefor  
6,224,870  Vaccine compositions and methods of modulating immune responses  
6,222,029  5′ ESTs for secreted proteins expressed in brain  
6,221,647  Efficient construction of gene targeting using phage-plasmid recombination  
6,221,643  Methods for diagnosis and treatment of Bloom’s syndrome  
6,218,510  B7-1 and B7-2 polypeptides  
6,218,356  Neural receptor tyrosine kinase  
6,218,181  Retroviral packaging cell line  
6,218,162  SH2-containing inositol-phosphatase  
6,215,041  Cloning using donor nuclei from a non-quiesecent somatic cells  
6,214,597  CSAPK-3 protein and uses therefor  
6,210,921  CAR: a novel coxsackievirus and adenovirus receptor  
6,207,876  Adenosine deaminase deficient transgenic mice and methods for the use thereof  
6,207,450  Glaucoma therapeutics and diagnostics based on a novel human transcription factor  
6,207,431  Glutamine:fructose-6-phosphate amidotransferase, its production and use  
6,204,432  PA28 modified transgenic mice  
6,204,364  Hybrid cytokines  
6,204,035  Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids  
6,204,013  MSP-5 nucleic acid molecules and uses therefor  
6,201,168  Pathogenesis of cardiomyopathy  
6,201,107  Cystic fibrosis gene  
6,200,806  Primate embryonic stem cells  
6 6,200,780  Human interferon-.epsilon.(IFN-.epsilon.), a type I interferon  
6,200,770  Protein kinase molecules and uses therefor  
6,200,769  Mammalian CDP-diacylglycerol synthase  
6,200,567  Therapeutic agents as cytokine antagonists and agonists  
6,197,928  Fluorescent protein sensors for detection of analytes  
6,197,751  Thymosin .alpha.1 promotes tissue repair, angiogenesis and cell migration  
6,197,578  Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection  
6,197,575  Vascularized perfused microtissue/micro-organ arrays  
6,197,551  Spoil-1 protein and nucleic acid molecules and uses therefor  
6,197,530  GPR10 as a target for identifying weight modulating compounds  
6,194,635  Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine  
6,194,633  Non-human animal having a functionally disrupted SLP-76 gene  
6,194,212  Vectors comprising SAR elements  
6,194,152  Prostate tumor polynucleotide compositions and methods of detection thereof  
6,194,151  Molecules of the TNF receptor superfamily and uses therefor  
6,191,154  Compositions and methods for the treatment of Alzheimer’s disease, central nervous system injury, and inflammatory diseases  
6,190,910  Mouse embryonic stem cell lines  
6,190,887  Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein  
6,190,874  Methods for identifying compounds that bind to CSAPK-1  
6,187,992  Transgenic mouse having a disrupted amyloid precursor protein gene  
6,184,436  Transgenic mice expressing HIV-1 in immune cells  
6,184,035  Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells  
6,183,993  Complement-resistant non-mammalian DNA viruses and uses thereof  
6,183,962  Protein kinase molecules and uses therefor  
6,183,744  Immunotherapy of B-cell malignancies using anti-CD22 antibodies  
6,180,358  Methods for identifying compounds that bind to CSPAK-2  
6,177,244  NPG-1 gene that is differentially expressed in prostate tumors  
6,174,682  Thioredoxin family active site molecules and uses therefor  
6,174,674  Method of detecting a chromosomal rearrangement involving a breakpoint in the ALK or NPM gene  
6,172,278  Ikaros transgenic cells and mice  
6,171,824  Hybrid cytokines  
6,168,933  Phospholipid transfer protein  
6,166,289  IRAK modified transgenic animals  
6,166,192  PGC-1, a novel brown fat PPAR.gamma. coactivator  
6,166,178  Telomerase catalytic subunit  
6,165,755  Chicken neuropeptide gene useful for improved poultry production  
6,165,748  Frazzled nucleotide sequences and expression products  
6,165,719  hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target  
6,162,963  Generation of Xenogenetic antibodies  
6,162,616  Multidrug resistance-associated polypeptide  
6,159,691  Assay for a putative regulator of cell cycle progression  
6,156,733  Use of leukemia inhibitory factor and endothelin antagonists  
6,156,569  Prolonged culturing of avian primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians  
6,156,306  Pancreatic .beta.-cells for allogeneic transplantation without immunosuppression  
6,153,428  .alpha.(1,3) galactosyltransferase negative porcine cells  
6,153,417  CSAPK-1 protein and uses therefor  
6,150,169  Expression of the heterologous genes according to a targeted expression profile  
6,147,276  Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos  
6,146,888  Method of enriching for mammalian stem cells  
6,146,841  Methods for identifying compounds that bind to CSAPK-3 molecules and fragments thereof  
6,146,832  Protein kinase molecules and uses therefor  
6,143,566  Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof  
6,143,540  Molecules of the HKID-1-related protein family and uses thereof  
6,140,121  Methods and compositions to improve germ cell and embryo survival and function  
6,140,083  Leptospiral outer membrane protein, LipL46  
6,140,056  MSP-18 protein and nucleic acid molecules and uses therefor  
6,139,835  Homologous recombination for allogeneic donor cells  
6,136,964  Mammalian lysophosphatidic acid acyltransferase  
6,136,958  Antibodies to vertebrate smoothened proteins  
6,136,954  Tetracycline-inducible transcriptional activator fusion proteins  
6,136,539  Compositions and methods for the inhibition of MUC-5 mucin gene expression  
6,136,040  Animal model with disrupted FGF-9 gene  
6,133,503  Mammalian artificial chromosomes and methods of using same.